- Moderna said in a statement on Friday that it is suing Pfizer and its German partner BioNTech for patent infringement while developing the first COVID-19 vaccine approved in the United States.
- The mRNA technology deployed in the Moderna and BioNTech-Pfizer shots differs from those used in traditional vaccines.
- Instead, mRNA vaccines deliver instructions to cells to build a harmless piece of the spike protein found on the surface of the virus.
Moderna suing Pfizer, Biontech for patent infringement over COVID vaccine 26.08.2022
